Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 105 (1) , 147-153
- https://doi.org/10.1016/s0022-5223(19)33859-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary ResultsThe Thoracic and Cardiovascular Surgeon, 1989
- PLATELET PRESERVATION BY APROTININ DURING CARDIOPULMONARY BYPASSThe Lancet, 1988
- Detection of coronary artery bypass graft patency as assessed by magnetic resonance imagingThe British Journal of Radiology, 1988
- Hypothermia-induced Reversible Platelet DysfunctionAnnals of Surgery, 1987
- Bleeding after Cardiopulmonary BypassNew England Journal of Medicine, 1986
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirinThe American Journal of Cardiology, 1981